Skip to main content
Hanna Barriga on Muck Rack

Hanna Barriga

As seen in: ACS Publications, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hanna

Contact Hanna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Single particle profiler for measuring content and properties of nano-sized bioparticles

|
By Taras Sych, Jan Schlegel, Hanna Barriga, Miina Ojansivu
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (696) Issue with article?

Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles

|
By Jeremy P. Bost, Hanna Barriga, Margaret N. Holme, Audrey Gallud
| ACS Publications
RNA Therapeutics Overview The field of nucleic-acid-based therapeutics is entering an era highlighted by increased clinical success and intense interest by pharmaceutical and biotech industries. The continuous improvements in nucleic-acid-based drug compositions along with the extensive mapping of genetic targets are fueling the exponential growth of applications for these therapies.
Open in Who Shared Issue with article?
See all 2 articles